RP

Reema Poddar

Active Director Director DIN 09422768
DIN 09422768 First appointment Dec 2021 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2021
Shareholding value •••• Premium profile

About Reema Poddar

Data last updated:

Reema Poddar is a Director at Kjr Genetics Private Limited (since 2021). The company operates in Healthcare. Kjr Genetics Private Limited reported revenue of ₹7.12 Cr (FY 2025).

DIN 09422768
Primary Designation Director
Industry Healthcare
First Appointment 02 Dec 2021
Oldest Company Age 8 yrs
Largest company Kjr Genetics Private Limited · ₹7.12 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Kjr Genetics Private Limited U74999WB2018PTC226234
Director02 Dec 20212018₹7.12 Cr (FY 2025)Active

Board colleagues of Reema Poddar

Directorship timeline

Open interactive timeline →
Kjr Genetics Private Limited
Premium access

Shareholding and investment profile for Reema Poddar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Reema Poddar

Reema Poddar currently holds 1 directorship: Kjr Genetics Private Limited (Director, since 02 Dec 2021, revenue ₹7.12 Cr (FY 2025)).

Reema Poddar was first appointed on 02 Dec 2021 as Director at Kjr Genetics Private Limited.

The current boards of Reema Poddar's companies include Jharna Podder (Kjr Genetics Private Limited), Kashinath Poddar (Kjr Genetics Private Limited), Rajat Poddar (Kjr Genetics Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available